AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Specimens for Lung Cancer Panel Design

Recruitingn/aAges 18 Years - anyAllMaverix Medical
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This is an observational study designed to determine the optimal combination of biomarkers and clinical data for the early detection, confirmation, and better treatment of lung cancer including minimizing recurrence.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
6.1 Criteria for the no prior cancer suspicious nodule arm Inclusion: 1. The patient has at least one indeterminant nodule with a diameter greater than or equal to 5mm and a Mayo SPN risk greater than 5%, identified by radiology, that has not been biopsied or undergone surgery. 2. The patient and the treating physician intend to follow up on the nodule with a biopsy procedure, PET scan, or active surveillance, with the procedure or next surveillance planned within the next 7 months. 3. Ability to understand the study and sign an informed consent form 4. Relevant clinical data accessible 5. Ability and willingness to safely donate 40 mL of blood 6. Ability of the site to collect and process blood per protocol Exclusion 1\. The patient has one or more nodules with a Mayo SPN risk over 50% or a diameter of 30mm or greater. 2\. The patient has received surgical prep, including antibiotics, anesthesia, etc. Fasting is not exclusionary. 3\. Previous cancer diagnosis of any origin. 4. Is currently pregnant 5. Is currently a prisoner or becomes a prisoner at any point during the study 6. Is under age 18, is unable to consent, or requires a different person or entity to consent on their behalf 6.2 Criteria for the previous cancer suspicious nodule arm Inclusion: 1\. The patient has at least one indeterminant nodule with a diameter greater than or equal to 5mm and a Mayo SPN risk greater than 5%, identified by radiology, that has not been biopsied or undergone surgery. 2\. The patient and the treating physician intend to follow up on the nodule with a biopsy procedure, PET scan, or active surveillance, with the procedure or next surveillance planned within the next 7 months. 3\. The patient has been in remission for a previous cancer not of lung origin for more than 5 years. 4\. Ability to understand the study and sign an informed consent form 5. Relevant clinical data accessible 6. Ability and willingness to safely donate 40 mL of blood 7. Ability of the site to collect and process blood per protocol Exclusion 1. The patient has one or more nodules with a Mayo SPN risk over 50% or a diameter of 30mm or greater. 2. The patient has received surgical prep, including antibiotics, anesthesia, etc. Fasting is not exclusionary. 3. Previous cancer diagnosis in the lung (either of lung origin or metastasis to the lung). 4. The treating physician believes the lung nodule is a recurrence of a previously diagnosed cancer. 5. Is currently pregnant 6. Is currently a prisoner or becomes a prisoner at any point during the study 7. Is under age 18, is unable to consent, or requires a different person or entity to consent on their behalf 6.3 Criteria for the healthy volunteer arm Inclusion: 1. Ability to understand the study and sign an informed consent form 2. Relevant clinical data accessible 3. Ability and willingness to safely donate up to 40 mL of blood 4. The ability of the site to collect and process blood per protocol Exclusion 1\. Is currently pregnant 2. Is currently a prisoner or becomes a prisoner at any point during the study 3. Is under age 18, is unable to consent, or requires a different person or entity to consent on their behalf
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Maverix Medical
Phoenix, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy